matching

(redirected from HLA matching)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.

Cash Flow Matching

The practice of matching returns on a portfolio to future capital outlays. That is, cash flow matching involves investing in certain securities with a certain expected return so that the investor will be able to pay for future liabilities. Pension funds and annuities perform the most cash flow matching, as they have future liabilities that are both large and relatively easy to estimate. Portfolios that perform cash flow matching usually invest in low-risk, investment-grade securities. The practice is also called portfolio dedication, matching, or the structured portfolio strategy.

matching

matching

the process of matching revenues and profits with the associated expenses incurred in earning these revenues. See ACCRUALS PRINCIPLE OF ACCOUNTING.
References in periodicals archive ?
Although the need for HLA matching of stem cell-derived therapies will likely vary depending on the tissue that is transplanted, matching will be critical to clinical success in at least some important therapeutic applications.
Although PGD operates negatively by screening and exclusion, its use for HLA matching might set a precedent for positive alteration and gene targeting, as might occur in germline gene therapy, nuclear transfer cloning, enhancement, or other nonmedical purposes.
New studies reveal that HLA matching can be reduced somewhat without compromising graft function.
Similarly, beyond the first posttransplant year, they said shipment had no impact on graft survival regardless of the degree of HLA matching.
The recipients, 76 blacks and 187 whites, were similar in age, degree of HLA matching, and incidence of diabetes as the cause of end-stage kidney disease.
Improved outcome of renal transplant as a result of better HLA matching is offset by prolonged cold ischemia times, a finding that adds to the debate over the utility of national sharing of donor kidneys.
Black transplant recipients are more likely than white recipients to have chronic rejection, a finding the authors said may be due to differences in immunologic responsiveness, HLA matching, or blood pressure control.